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Although hepatitis C virus (HCV) assembly remains incompletely understood, recent studies with the
genotype 2a JFH-1 strain suggest that it is dependent upon the phosphorylation of Ser residues near the C
terminus of NS5A, a multifunctional nonstructural protein. Since genotype 1 viruses account for most HCV
disease yet differ substantially in sequence from that of JFH-1, we studied the role of NS5A in the production
of the H77S virus. While less efficient than JFH-1, genotype 1a H77S RNA produces infectious virus when
transfected into permissive Huh-7 cells. The exchange of complete NS5A sequences between these viruses was
highly detrimental to replication, while exchanges of the C-terminal domain III sequence (46% amino acid
sequence identity) were well tolerated, with little effect on RNA synthesis. Surprisingly, the placement of the
H77S domain III sequence into JFH-1 resulted in increased virus yields; conversely, H77S yields were reduced
by the introduction of domain III from JFH-1. These changes in infectious virus yield correlated well with
changes in the abundance of NS5A in RNA-transfected cells but not with RNA replication or core protein
expression levels. Alanine replacement mutagenesis of selected Ser and Thr residues in the C-terminal domain
III sequence revealed no single residue to be essential for infectious H77S virus production. However, virus
production was eliminated by Ala substitutions at multiple residues and could be restored by phosphomimetic
Asp substitutions at these sites. Thus, despite low overall sequence homology, the production of infectious virus
is regulated similarly in JFH-1 and H77S viruses by a conserved function associated with a C-terminal Ser/Thr
cluster in domain III of NS5A.
Infection with hepatitis C virus (HCV) is associated with
chronic hepatitis, progressive hepatic fibrosis leading to cirrho-
sis, and hepatocellular carcinoma (for a review, see reference
21). The virus establishes lifelong persistent infection in most
infected persons. It is currently thought to infect 130 to 170
million people worldwide, placing them at risk for potentially
life-threatening liver disease. Available interferon-based treat-
ment is limited in its efficacy, and immunization currently is not
possible. To overcome these shortcomings in therapeutic and
preventive measures, there is a need to increase our current
understanding of HCV pathogenesis, including the molecular
mechanisms involved at various steps in the virus life cycle and
the role of virus-host interactions in virus persistence and dis-
ease progression.
HCV is an enveloped, positive-strand RNA virus classified
within the genus Hepacivirus of the family Flaviviridae. Its
9.7-kb genome encodes a single polyprotein, which is co- and
posttranslationally processed by both viral and cellular pro-
teases (21). The N-terminal segment of the polyprotein com-
prises the structural proteins (core, E1, and E2), while the
downstream proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, and
NS5B) are nonstructural. Only the segment extending from
NS3 to NS5B is required for genome replication (24), with
NS5B, an RNA-dependent RNA polymerase, serving as the
catalytic core of a membrane-bound, macromolecular viral
replicase complex. p7 and NS2 are not required for RNA
replication, and accumulating evidence supports important
functions for both of these proteins in virus assembly and the
release of virus from infected cells (18, 19, 26, 37, 45, 48).
Emerging data also support essential roles for other nonstruc-
tural proteins, in particular NS5A (2, 16, 28, 32, 39) and NS3
(27, 32, 47), in the assembly and release of infectious particles.
The HCV NS5A protein is unique, with no known human or
viral homologs other than NS5A in the closely related GB virus
B (GBV-B). It appears to have multiple functions in the virus
life cycle and to interact with numerous viral and host proteins
(43), but little is known about NS5A at a mechanistic level. It
is required for viral RNA replication and, as mentioned above,
plays an essential role in virion production. It is a phospho-
protein (15, 20, 38), and its phosphorylation status was sug-
gested to regulate genome replication and virus assembly (11,
12). It is also a frequent site of cell culture-adaptive mutations
that promote the amplification of HCV replicon RNAs in
Huh-7 hepatoma cells (3). At a structural level, there appear to
be three distinct domains that are separated by segments of the
protein that are relatively disordered. The N-terminal domain
(domain I) contains a Zn-binding motif and is essential for
viral RNA replication (41). Two high-resolution structural
models have been developed for domain I of NS5A based on
X-ray crystallography (25, 42). While they differ significantly,
both models suggest a dimeric structure that associates with
lipid bilayers in membrane-bound replicase complexes. Impor-
tantly, NS5A mutants that are deficient in the ability to support
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viral RNA replication can be trans-complemented in a cell
culture system (1).
The middle domain II, which is involved in antagonizing
innate immune responses, and C-terminal domain III of NS5A
appear to play lesser roles in viral RNA replication (30, 40).
Nonetheless, mutations within domain III may reduce the ef-
ficiency of genome amplification. The amino acid sequence of
domain III is poorly conserved between different viral geno-
types and has been considered to be relatively unstructured
(14). Nonetheless, recent data suggest that it plays an impor-
tant role in the assembly of infectious virus particles. This
aspect of NS5A function has emerged from studies of the
genotype 2a JFH-1 virus, a unique strain of HCV that repli-
cates efficiently in cell culture. The transfection of synthetic
JFH-1 genomic RNA produces relatively high titers of infec-
tious virus in permissive Huh-7 hepatoma cells (22, 44, 52).
During an early step in the process of particle assembly, the
JFH-1 NS5A protein is recruited to the surface of cytoplasmic
lipid droplets that are decorated with the viral core protein (6,
29). Genetic evidence also suggests that NS5A, in association
with NS2, acts at a later step in virus production, following
intracellular particle assembly but prior to the release of in-
fectious virus (48). Several recent studies indicated that do-
main III of the JFH-1 NS5A protein is particularly important
for the production of infectious virions and that the phosphor-
ylation of Ser residues within this domain, possibly by cellular
casein kinase II (CK II), is required for this process (2, 16,
28, 39).
We have found the construction and analysis of intergeno-
typic chimeric HCV genomes to be a productive approach to
the characterization of functional interactions among HCV
proteins that are important in the virus life cycle (27, 47). We
adopted a similar approach to investigate the role of NS5A in
the production of infectious virus, generating intergenotypic
NS5A chimeras within the background of JFH-1 and a geno-
type 1a molecular clone, H77S, that also produces infectious
particles when transfected into cells as RNA (49). H77S RNA
produces substantially fewer infectious particles in transfected
cells than does JFH-1 RNA, but like JFH-1 virus produced in
cell culture (23), recent studies have shown that virus produced
from H77S RNA (with an additional adaptive mutation in E2)
is infectious for chimpanzees as well (data not shown).
We exchanged the entire NS5A sequences between these
two genotypes, as well as only the domain III sequences, and
observed the effects of these exchanges on intracellular ge-
nome amplification and infectious virus production. We also
carried out a mutational analysis of potential phosphoacceptor
sites within the C-terminal domain III sequence of the NS5A
protein in the H77S virus and compared these results with
results of previously reported studies of the JFH-1 virus. De-
spite limited sequence identity, our data indicate that domain
III of the genotype 1a H77S NS5A protein shares conserved
structural and functional elements with the JFH-1 protein that
are essential for the production of infectious virions.
MATERIALS AND METHODS
Plasmids. The cell culture-adapted pH77S infectious molecular clone of ge-
notype 1a HCV was described previously (49). pH77S.3 is a modified version of
this plasmid that has an enhanced capacity for the production of infectious virus
in cell culture and that contains an additional N476D mutation in E2 and lacks
the Q1067R adaptive mutation in NS3 (36). “No see’m” cloning (50) was used to
generate NS5A chimeras in the pH77S (49), pJFH-1 (44), and chimeric inter-
genotypic pHJ3-5 (47) plasmid DNAs without altering the original genome
sequences outside NS5A or NS5A domain III. The SapI restriction enzyme was
employed for the deletion and insertion of heterologous sequences since its
recognition site is nonpalindromic. For Ser/Thr-to-Ala or -Asp substitution mu-
tations, the QuikChange mutagenesis kit (Stratagene) was used. DNA sequenc-
ing verified the integrity of the manipulated sequences and the presence of the
intended substitution mutations.
Cells. Huh-7.5 cells (4) were kindly provided by Charles Rice and Apath, LLC.
The cells were grown in high-glucose Dulbecco’s modified Eagle’s medium
(DMEM) containing 10% fetal bovine serum and 1 penicillin-streptomycin at
37°C in a 5% CO2 environment.
RNA transcription and transfection. Plasmid DNAs were linearized by XbaI
restriction digestion. Synthetic RNA was transcribed from linearized DNAs
using the MEGAscript kit (Ambion). The concentration and integrity of the
transcribed RNAs were confirmed by spectrophotometry and denaturing agarose
gel electrophoresis. In vitro-transcribed RNAs (1.25 g) were transfected into
Huh-7.5 cells in six-well culture dishes (6  105 cells/well) using the TransIT-
mRNA transfection reagent (Mirus Bio) as recommended by the manufacturer.
Six hours after transfection, the culture medium was replaced with fresh medium.
The cells were split at a 1:2 ratio before further incubation at 37°C in a 5% CO2
incubator.
DNA transfection. For NS5A protein expression studies, 0.9 g of plasmid
DNA was mixed with 0.1 g of the pCMV-GLuc plasmid (New England Bio-
Labs) and transfected into Huh-7.5 cells in 12-well culture dishes (2  105
cells/well) using TransIT-2020 reagent (Mirus Bio) as recommended by the
manufacturer. NS5A species were quantified in immunoblots using different
antibody probes (see below), and the results were normalized to the luciferase
activity present in supernatant fluids of transfected cultures.
Virus titration. Culture supernatants were collected 3 days after transfection
with the synthetic RNAs, and the titer of infectious virus was determined by the
inoculation of serial 10-fold dilutions onto naïve Huh-7.5 cells seeded 1 day
previously in 8-well chamber slides (Lab-Tek) (1  105 cells/well). Three days
after inoculation, infected cells were fixed with methanol-acetone and labeled for
the detection of the HCV core protein by immunofluorescence microscopy as
described previously (27). The titer of infectious virus was determined from the
number of foci of infected cells observed at each dilution and is expressed as
focus-forming units (FFU) per ml. To quantify intracellular infectious virus, cell
lysates were prepared by multiple freeze-thaw cycles as described previously (13)
and similarly tested.
Immunoblots. A standard immunoblotting procedure was employed (35). Pro-
tein samples transferred onto polyvinylidene difluoride (PVDF) membranes
were probed with the following primary antibodies: anti-core (1:2,000) (MA1-
080; Affinity BioReagents), 9E10 (kindly provided by Charles Rice and Tim
Tellinghuisen), rabbit polyclonal anti-NS5A (kindly provided by Craig Cam-
eron), anti-NS3 (217-A; Virogen), anti-actin (A5441; Sigma), anti-Myc (catalog
number 2278; Cell Signaling), and anti-glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) (AM4300; Ambion). Proteins were visualized with horseradish
peroxidase-conjugated anti-mouse or anti-rabbit IgG (catalog numbers 103005
and 405005; Southern Biotech) and enhanced chemiluminescence detection
(Amersham ECL-GE Healthcare). For the quantitative assessment of immobi-
lized proteins, proteins were visualized with IRDye 800CW goat anti-mouse IgG
or IRDye 680 goat anti-rabbit IgG, and images were collected with an Odyssey
infrared imaging system (Li-Cor Biosciences).
HCV core ELISA. The amount of soluble HCV core protein released into the
cell culture medium by transfected cells was quantified by using the Ortho
Diagnostics Trak-C enzyme-linked immunosorbent assay (ELISA) kit (Ortho-
Clinical Diagnostics) according to the manufacturer’s instructions.
RT-PCR. For the quantitative measurement of the HCV RNA replication
capacity, Huh-7.5 cells were transfected by electroporation (46), and total cel-
lular RNA was isolated at the time of harvest by using the RNeasy minikit
(Qiagen). Real-time quantitative reverse transcription (RT)-PCRs (qRT-PCRs)
were carried out with the iQ5 real-time PCR detection system (Bio-Rad) as
described previously (27).
CK II inhibitor treatment. Cell cultures were split as described above 6 h after
HCV RNA transfection and refed with medium containing 2-dimethylamino-
4,5,6,7-tetrabromo-1H-benzimidazole (DMAT), a specific CK II inhibitor (Cal-
biochem). The cells were incubated for 48 h, followed by the refeeding of the
cells with fresh medium (no DMAT). Culture supernatant fluids were collected
1 day later and assayed for infectious virus as described above. The cytotoxic
effects of DMAT were assessed by using the WST-1 cellular proliferation assay
(Roche Applied Sciences) as recommended by the manufacturer.
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RESULTS
Intergenotypic NS5A domain exchanges and genome repli-
cation. Genome-length HCV RNAs transcribed from geno-
type 2a plasmid pJFH-1 and genotype 1a plasmid pH77S pro-
duce infectious virus particles when transfected into Huh-7
hepatoma cells (44, 49, 52). As described above, several pre-
vious studies suggested that C-terminal domain III of the
NS5A protein is essential for the assembly of infectious JFH-1
virus particles and that the phosphorylation of this domain may
regulate assembly (2, 16, 28, 39). While it is likely that this is
also true for the genotype 1a H77S virus, the genotype 1a
NS5A protein has not been similarly investigated. Since geno-
type 1 infections account for the large majority of infections in
most geographic regions (31), it is important to study these
events in the context of genotype 1 viruses. This is especially
important since the H77S NS5A protein shares only 58%
amino acid identity with the JFH-1 protein overall and only
46% identity within domain III (Fig. 1A). To determine
whether these NS5A proteins can function interchangeably,
despite the differences in amino acid sequences, we exchanged
sequences encoding the entire NS5A protein, or the NS5A
domain III only, within the background of these full-length
constructs (Fig. 1B). To avoid any changes in the HCV se-
quence outside the exchanged domains, we employed “no
see’m” cloning (50) to generate the mutants. The chimeric
sequences were verified by sequencing of the plasmid DNAs.
The impact of these NS5A domain swaps on RNA replica-
tion was determined following their transfection into Huh-7.5
cells by using a real-time, quantitative RT-PCR assay to com-
pare the RNA abundance relative to the abundance of a rep-
lication-defective control RNA containing a GND substitution
in the GDD motif of NS5B (Fig. 1C). These results demon-
strated similar increases in the relative intracellular abun-
dances of the parental H77S and JFH-1 RNAs over the 72 h
following transfection (Fig. 1C, left and right, respectively). In
contrast, both chimeric RNAs with full-length NS5A swaps
demonstrated significant impairments in RNA replication. The
JFH-1/H5A RNA (H77S NS5A in the JFH-1 background)
(Fig. 1B) showed no increase in abundance compared to that
of the lethal GND mutant (Fig. 1C, right), while the H77S/J5A
RNA demonstrated a 10-fold reduction in RNA abundance
compared with that of the parental H77S RNA by 72 h post-
transfection (Fig. 1C, left). Consistent with these findings, no
core protein expression was observed for cells transfected with
either of these full-length NS5A chimeras (Fig. 1D, lanes 2 and
5). These results thus demonstrate that major differences in the
sequences and/or structures of the genotype 1a and 2a NS5A
proteins preclude them from functioning interchangeably in
support of viral RNA replication.
Very different results were obtained with the chimeras in
which only domain III of NS5A was exchanged: both replicated
in a fashion very similar to that of the related parental RNAs
FIG. 1. Construction and evaluation of replication properties of NS5A chimeras. (A) Amino acid sequences of NS5A domain III in H77S and
JFH-1 viruses. The amino acid sequence identity between these two domains is 46.2%. (B) Schematic diagram of the NS5A chimeras constructed
for these studies. The entire NS5A sequence or NS5A domain III was exchanged between H77S and JFH-1 to assess the impact on infectious virus
production and viral RNA replication. (C) Replication properties of transfected H77S (left) and JFH-1 (right) chimeric RNAs. The abundance
of in vitro-transcribed genomic RNA relative to that of a replication-defective mutant with a GND mutation in NS5B was determined at various
times following transfection by using a real-time RT-PCR assay. Shown are mean values  standard errors (SE) from triplicate RT-PCR assays.
(D) Immunoblots of lysates of HCV RNA-transfected cells showing the abundance of core and NS5A in comparison to actin and GAPDH loading
controls, respectively. Faint bands are indicated to their left as follows: “x,” H77S NS5A; “o,” H77S/J5Ad3 NS5A; “s,” additional hyperphosphor-
ylated NS5A species (see the text); “,” nonspecific band. The predicted molecular masses of the H77S, JFH-1, and chimeric NS5A proteins, prior
to any posttranslational modification, are shown between the NS5A and GAPDH blots. Pred. NS5A m.w., predicted NS5A molecular weight (in
thousands).
VOL. 85, 2011 ROLE OF NS5A DOMAIN III OF GENOTYPE 1a HCV 6647
(Fig. 1C). A modest decrease in the accumulation of H77S/
J5Ad3 RNA (H77S background with NS5A domain III of
JFH-1) (Fig. 1B) relative to that of the parental H77S RNA,
evident at 24 h only (Fig. 1C, left), was matched by a small
reduction in the level of core protein expression detectable by
immunoblotting (Fig. 1D, lane 3 versus lane 1). However, any
impact of the domain III swap on viral RNA replication was
minimal and was completely undetectable in the JFH-1 back-
ground. This indicates that the major incompatibilities that
preclude the functional exchange of the full-length NS5A pro-
teins with respect to viral RNA replication reside upstream of
domain III and in domain I or II.
Intergenotypic NS5A domain exchanges and infectious virus
production. Infectious virus particles released by RNA-trans-
fected Huh-7.5 cells were quantified by a fluorescent-focus
infectivity assay (49, 52). Although no overlay is used in this
assay, we have confirmed that there is a linear relationship
between the number of focus-forming units (FFU) obtained
and the dilution of an HCV inoculum (our unpublished data).
This correlation indicates that each focus is initiated by a single
infectious particle and validates the assay. Both parental RNAs
(H77S and JFH-1) produced infectious virus that was detect-
able in culture supernatant fluids by 3 days posttransfection,
although about 10-fold more infectious virus was secreted into
the medium of cells transfected with JFH-1 versus H77S RNA
(Fig. 2A), as described previously (49). Nonetheless, the titer
of the infectious H77S virus produced in these experiments was
sufficient to reliably determine the impact of NS5A domain
exchanges on infectious virus production. No infectious virus
was released from cells transfected with the H77S/J5A or JFH-
1/H5A chimeric RNAs even when monitored up to 5 days after
transfection. This is consistent with the impairments found in
viral RNA replication described above (Fig. 2A). In contrast,
the intergenotypic exchange of domain III only (H77S/J5Ad3
and JFH-1/H5Ad3) resulted in RNAs that could produce in-
fectious virus despite the low level of amino acid sequence
identity shared by these domains (46%) (Fig. 1A and 2A).
Interestingly, when domain III of H77S NS5A was placed
within the JFH-1 background, there was a significant increase
(variable but averaging almost 10-fold in replicate experi-
ments) in the infectious virus yield (Fig. 2A). As discussed
above, this occurred without any significant change in intracel-
lular RNA replication (Fig. 1C, right) or intracellular core
abundance (Fig. 1D, lanes 4 and 6). The reverse exchange
(domain III of JFH-1 into the H77S background) resulted in a
60% decrease in the infectious virus yield at 3 days (Fig. 2A).
While there was no difference in the intracellular abundances
of the H77S and H77S/J5Ad3 RNAs at 48 to 72 h (Fig. 1C,
left), the intracellular core abundance was somewhat reduced
in H77S/J5Ad3-transfected cells (Fig. 1D, lane 1 versus lane 3).
Collectively, these results are consistent with a major role for
domain III of NS5A in the assembly of infectious particles, as
described previously (2, 16, 28, 39). These results also demon-
strate that domain III from genotype 1a NS5A and domain III
from genotype 2a NS5A function interchangeably with respect
to virus assembly and release, albeit with various efficiencies,
and that the substantially higher yield of infectious virus ob-
tained with JFH-1 than that obtained with H77S is not due to
a better functionality in this domain of NS5A. In fact, some-
what surprisingly, the H77S NS5A domain functions more
efficiently in virus assembly and release than does the native
JFH-1 NS5A domain.
The amount of core protein released into supernatant cell
culture fluids has been used as a surrogate measure of the
production of infectious JFH-1 virus (29) but does not corre-
late well with the release of infectious H77S virus from cells
(49). As shown in Fig. 2B, the core protein was detected by
ELISA in medium from cultures transfected with each of the
chimeric RNAs that were capable of producing infectious virus
but not with the two RNAs with complete NS5A swaps and
impaired viral RNA replication (Fig. 2B). However, while the
reduction in amount of infectious H77S/J5Ad3 virus compared
to H77S was matched by a comparable reduction in the
amount of core protein released into the supernatant fluids,
this was not the case with the JFH-1/H5Ad3 chimera. The
reproducible increase in virus yield observed with JFH-1/
H5Ad3 versus JFH-1 RNA (Fig. 2A) was not matched by an
increase in the extracellular core abundance (Fig. 2B). We
conclude from these results that the measurement of extracel-
lular core abundance by ELISA is not always a reliable indi-
cator of cell culture-infectious HCV yield despite its use as
such in the past.
NS5A expression and infectious virus yields. While the level
of intracellular core expression was greater in cells transfected
with JFH-1 RNA versus H77S RNA (and their related domain
III chimeras), immunoblot analyses suggested much greater
differences in NS5A expression (Fig. 1D). A much stronger
NS5A signal, appearing as two distinct bands (presumably hypo-
FIG. 2. (A) Virus yields (extracellular culture fluids) from RNA-
transfected cells after intergenotypic (genotype 1a32a and genotype
2a31a) exchanges of NS5A or NS5A domain III. Culture superna-
tants obtained at day 3 after transfection were assayed for infectious
virus. Shown are the mean yields from each chimera in triplicate
transfections  standard deviations (SD). (B) ELISA for the HCV
core protein present within supernatant culture fluids of RNA-trans-
fected cells. Data shown represent mean values  SE determined from
duplicate experiments.
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and hyperphosphorylated isoforms), was present in immuno-
blots of lysates of the genotype 2a JFH-1-transfected cells than
in lysates from the genotype 1a H77S-transfected cells. Inter-
estingly, there was a rough correlation between the abundance
of NS5A and the production of infectious virus by the 4 dif-
ferent RNAs. The NS5A expression levels were highest with
JFH-1/H5Ad3, somewhat lower in cells transfected with JFH-1
RNA, and markedly reduced, evident only as a single band and
only with the prolonged exposure of the blots, with H77S (Fig.
1D, compare lanes 6, 4, and 1). An even fainter, single band
was at the extreme limits of detection in lysates of cells trans-
fected with H77S/J5Ad3 (Fig. 1D, lane 3). Despite the sub-
stantial difference in the amino acid sequences of the H77S
and JFH-1 proteins, this striking difference in the apparent
abundance of NS5A is unlikely to be due to antigenic variation.
The monoclonal antibody used in these blots (9E10) was raised
against a genotype 1b (Con1 strain) NS5A protein (22), the
amino acid sequence of which is 80% identical to that of H77S
NS5A but only 61% identical to that of JFH-1. In addition,
similar results were observed with a rabbit polyclonal antibody
to genotype 1b NS5A (data not shown). These results are thus
more likely to reflect significant differences in absolute NS5A
abundances.
Nonetheless, to confirm that the 9E10 antibody efficiently
detects H77S NS5A and to ascertain whether there is any bias
in its recognition of genotype 1a versus genotype 2a NS5A, we
ectopically expressed these proteins with an N-terminal Myc
tag in Huh-7.5 cells. We then probed immunoblots of cell
lysates with 9E10 and an anti-Myc antibody in parallel (Fig.
3A), quantifying the signal obtained with each antibody. These
results revealed that the JFH-1/H5Ad3 chimeric protein bound
significantly more 9E10 than anti-Myc antibody (explaining the
more intense labeling of this protein in Fig. 1D) but demon-
strated that there is no significant difference in the recognition
of H77S versus JFH-1 NS5A by 9E10 (Fig. 3B). This confirms
that the remarkable differences observed for immunoblots of
NS5A in lysates of cells transfected with H77S versus JFH-1
RNA (Fig. 1D) reflect absolute differences in protein abun-
dance. In contrast to what was observed for cells transfected
with replication-competent viral RNAs (Fig. 1D), ectopically
expressed JFH-1 NS5A migrated as a single protein band (Fig.
3A). A direct comparison indicated that this was the hypophos-
phorylated species, while ectopically expressed H77S NS5A
appeared to be hyperphosphorylated (data not shown).
Collectively, these results suggest that the infectious virus
yield might be limited by the abundance of NS5A more than
viral RNA replication. Since lesser differences were observed
for the expression levels of the core protein (and core and
NS5A are processed from the same polyprotein), the large
differences observed in NS5A abundance suggest that the
H77S NS5A protein may be less stable than JFH-1 NS5A.
Immunoblots showed no consistent difference in the abun-
dances of H77S NS5A and JFH-1 NS5A when these proteins
were expressed ectopically in Huh-7.5 cells (Fig. 3), indicating
that there is little intrinsic difference in the stabilities of these
proteins. While it remains possible that the stabilities of the
phosphorylated proteins differ within infected cells, the low
level of NS5A expressed by replicating H77S RNA precluded
a formal comparison of its stability with the JFH-1 protein.
It would not be surprising if differences in the phosphoryla-
tion status of NS5A also impacted the function of the proteins
expressed by genotype 1a and 2a RNAs. Differences in the
predicted molecular masses of the genotype 1a, 2a, and chi-
meric NS5A proteins (Fig. 1D) confound a direct comparison
of their phosphorylation statuses by simple gel analysis. None-
theless, there are clear differences evident in the immunoblot
shown in Fig. 1D. JFH-1 NS5A was expressed as two isoforms
of approximately equal abundance, with a modest increase in
the hypophosphorylated form in cells transfected with the
JFH-1/H5Ad3 RNA relative to the hyperphosphorylated iso-
form (Fig. 1D, compare lanes 4 and 6). In some but not all
experiments, we also noted a small amount of a third JFH-1/
H5Ad3 band migrating with an apparent molecular mass
higher than that of the hyperphosphorylated form (Fig. 1D,
lane 6, “s”). In contrast, as noted above, only a single NS5A
band was evident in cells transfected with H77S and H77S/
J5Ad3 RNAs. While the phosphorylation status of the single
H77S NS5A band was difficult to assess with these experi-
ments, it is interesting that it migrated more rapidly in SDS-
FIG. 3. Ectopically expressed NS5A proteins. (A) Expression vec-
tors encoding various NS5A molecules, each with an N-terminal Myc
tag, were transfected into Huh-7.5 cells along with a second vector
expressing Gaussia luciferase as a transfection control. Cell lysates
were prepared 72 h later and subjected to SDS-PAGE followed by
immunoblotting with the 9E10 monoclonal antibody or an anti-Myc
antibody. The results shown are representative of data from replicate
experiments. (B) 9E10 and anti-Myc antibodies bound by NS5A pro-
teins in parallel immunoblots of cell lysates were detected with an
infrared fluorescent probe and quantified by using an Odyssey fluo-
rescent scanner. Results for each antibody were normalized to the
amount bound by the JFH-1 protein. The results shown represent the
means  SE from 3 separate transfection experiments. The JFH-1/
H5Ad3 protein demonstrated a greater binding of 9E10 than of anti-
Myc, but there are no significant differences in the recognitions of
JFH-1 and H77S NS5A by these antibodies. The equivalent abundance
when the NS5A proteins were probed by anti-Myc antibody suggests
that there are no significant differences in the intrinsic stabilities of
these proteins. Differences in transfection efficiency, monitored by
assessing luciferase activity, were minimal.
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PAGE gels than did the hypophosphorylated JFH-1/H5Ad3
isoform despite having a higher predicted molecular mass in
the absence of posttranslational modifications (49.1 versus 47.9
kDa) (Fig. 1D, compare lanes 1 and 6). We were unable to
detect H77S NS5A in these cell lysates following treatment
with -PPase (data not shown). The apparent molecular mass
of the H77S protein in SDS-PAGE gels is addressed in addi-
tional detail below.
Domain III exchange promotes intracellular assembly of
JFH-1 virus. The enhanced release of infectious virus by cells
transfected with the chimeric JFH-1/H5Ad3 RNA compared
to that of its JFH-1 parent could be due to either an enhanced
assembly of intracellular particles or a facilitation of the re-
lease of such particles from the cell. To address this question,
we determined the amounts of infectious virus present in in-
tracellular and extracellular fractions of RNA-transfected
cells. Multiple freeze-thaw cycles were used to prepare intra-
cellular lysates 3 days after transfection, and the titer of infec-
tious virus present in these lysates and the related culture
supernatant fluids was determined by the infectious focus as-
say. While a somewhat lesser (3-fold) increase in the extra-
cellular infectious virus yield was observed for this series of
experiments than for those described above when cells were
transfected with the JFH-1/H5Ad3 chimera versus JFH-1
RNA, the abundance of intracellular infectious particles was
increased 30-fold (Fig. 4). Thus, it is likely that the primary
impact of the domain III swap is on enhanced viral assembly
within the cell and that the observed increase in the release of
infectious virus is secondary. Of all infectious virus present in
these cultures at 3 days posttransfection, 88% of the JFH-1
virus was present in the extracellular fluids, compared to only
49% of the JFH-1/H5Ad3 virus.
Since it is possible that the increase in the amounts of in-
tracellular infectious particles observed with the JFH-1/H5Ad3
RNA could reflect an enhanced interaction between NS5A and
the core protein coating lipid droplets (28, 29), we compared
the intracellular localizations of core and NS5A in cells trans-
fected with JFH-1/H5Ad3 and JFH-1 RNAs using laser scan-
ning confocal microscopy. These studies demonstrated no de-
tectable differences in the cellular localizations or in the
degrees of colocalization of these two viral proteins (data not
shown).
As an alternative approach to assessing the role of the struc-
tural proteins in the enhanced production of infectious virus by
JFH-1/H5Ad3, we created a similar domain III swap in the
background of the HJ3-5 virus, an intergenotypic chimera con-
taining the entire structural protein region (core through NS2)
from the genotype 1a H77S virus in the background of the
genotype 2a JFH-1 RNA (27, 47) (Fig. 5A). The JFH-1/H5Ad3
construct thus places H77S domain III back in context with the
H77S core protein. In contrast to the increase in the infectious
virus yield that we observed when domain III from H77S was
placed into the JFH-1 background (Fig. 2A), swapping the
H77S domain III into HJ3-5 caused nearly a 10-fold reduction
in the infectious virus yield (Fig. 5B) and a 30-fold decrease in
core protein secretion (Fig. 5C). This was associated with a
marked decrease in core protein expression levels as well as a
lower abundance of NS5A with the loss of most of the hyper-
phosphorylated isoform (Fig. 5D).
The NS5A proteins encoded by the JFH-1 and HJ3-5 viruses
are identical, and the proteins expressed by these two RNAs
each show a slight dominance of the faster migrating of the two
major isoforms of NS5A (compare Fig. 1D and 5D). JFH-1/
H5Ad3 and HJ3-5/H5Ad3 (which share the same chimeric
NS5A sequences in the background of JFH-1 nonstructural
proteins) were very different in this regard. JFH-1/H5Ad3 was
much like JFH-1, with only a slight dominance of the fast-
migrating species, while HJ3-5/H5Ad3 expressed mostly the
hypophosphorylated isoform, with little of the more slowly
migrating species present (compare again Fig. 1D and 5D). To
ascertain whether the domain III swap influenced RNA repli-
cation in the context of the HJ3-5 chimera, we compared RNA
replication kinetics in cells transfected with modified genomes
in which the envelope-coding regions had been deleted (to
prevent any confounding influence from infectious virus pro-
duction and virus spread in the transfected cell culture). These
results revealed that the NS5A domain III swap had a substan-
tial, negative effect on RNA replication in the context of the
genotype 1a/2a HJ3-5 chimera, resulting in a delay in RNA
amplification and a reduction in intracellular viral RNA accu-
mulation of approximately 10-fold (Fig. 5E). This is different
from the absence of any such effect when the H77S domain III
sequence was placed into the JFH-1 virus (Fig. 1C, right) and
explains the reduced core abundance in cells transfected with
HJ3-5/H5Ad3 RNA. However, the NS5A abundance was well
preserved relative to the amount of core protein present in
these cells (Fig. 5D). Collectively, these data provide genetic
evidence for interactions between NS5A and the upstream
structural proteins that influence the NS5A phosphorylation
status and the efficiency of genome amplification. While most
previous studies indicated that mutations in domain III have
little impact on the replication of viral RNA, recent data from
Hughes et al. (16) are also consistent with domain III playing
a role in RNA replication.
Virus production mediated by domain III of H77S NS5A is
sensitive to a CK II inhibitor. RNA interference (RNAi)-
FIG. 4. Infectious virus titer of cell culture supernatant fluids and
intracellular lysates of JFH-1 and JFH-1/H5Ad3 RNA-transfected
cells on day 3 after transfection. Lysates were prepared by multiple
freeze-thaw cycles. Shown are the means  SE from duplicate trans-
fections. Percentages are the proportions of the total virus yield re-
leased into supernatant (Sup) culture fluids (i.e., virus in supernatant/
virus in supernatant  virus in lysate).
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mediated gene silencing and chemical inhibitor studies re-
ported previously by Tellinghuisen et al. (39) suggested that
host CK II phosphorylates Ser-457 in domain III of the JFH-1
NS5A protein and that this is essential for the production of
infectious virus. To determine whether the assembly function
of domain III in H77S is equivalently sensitive to CK II inhi-
bition, we assessed the effect of the CK II inhibitor 2-di-
methylamino-4,5,6,7-tetrabromo-1H-benzimidaozle (DMAT)
on the production of infectious virus by JFH-1/H5Ad3 RNA,
which contains H77S domain III in the JFH-1 background.
Cells transfected with JFH-1 RNA were treated in parallel and
demonstrated a modest decrease in infectious virus yields at 1
M and a marked decrease at a 10 M concentration (Fig. 6A,
left). While the specificity of a kinase inhibitor is always cause
for concern, the data confirm that JFH-1 virus production is
inhibited by DMAT (39). However, under the conditions that
we used, virus production appeared to be less sensitive to
inhibition by the compound than reported previously. Impor-
tantly, JFH-1/H5Ad3 RNA was equally sensitive to the inhibi-
tion of infectious virus production by DMAT (Fig. 6A, right).
The abundances of NS5A and NS2 were moderately reduced
at 10 M, while the abundance of NS3 did not seem to be
affected (Fig. 6B). Higher concentrations of DMAT were not
tested, as 10 M was at the cusp of significant cellular toxicity
under the conditions used, as determined by WST-1 cellular
proliferation assays (Fig. 6C). These results are consistent with
the H77S and JFH-1 domain III assembly functions being
equivalently sensitive to DMAT inhibition, although the effects
of the compound, both on virus production and on cellular
toxicity, were less than those previously described (39).
A conserved cluster of Ser residues in domain III of NS5A
regulates production of infectious H77S virus. There is only a
limited understanding of which of the many potential phos-
phoacceptor sites in the NS5A sequence are actually phosphor-
ylated during virus replication, the functional role of such
FIG. 5. Replication and infectious virus yields from the structural
protein chimera HJ3-5 with or without exchange of domain III of
NS5A from H77S virus. (A) Schematic showing the organization of the
HJ3-5 intergenotypic chimeric RNA and the related NS5A domain III
(d3) swap with the H77S sequence. The H77S sequence (core-NS2) is
shown as open boxes, while the JFH-1-derived sequence (NS3-NS5B)
is shaded; noncoding RNA segments are from JFH-1. The asterisks
indicate the location of compensatory mutations (E1 and NS3) that
promote yields of infectious virus from the chimera (27). In HJ3-5/
E1-p7 and E1-p7/H5Ad3, the E1-p7 sequence has been deleted.
(B) Infectious virus production. Shown are the means  ranges of
yields of infectious virus from chimeric RNAs, calculated from dupli-
cate transfections. (C) ELISA for core protein secreted by cells trans-
fected with HJ3-5 and HJ3-5/H5Ad3 RNAs. Means  SE were calcu-
lated from duplicate experiments. (D) Immunoblots for the HCV core
protein in lysates of HJ3-5 and HJ3-5/H5Ad3 RNA-transfected cells.
Actin served as a loading control. Also shown are immunoblots for
NS5A in lysates of cells transfected with the related E1-p7 mutant
RNAs; GAPDH was the loading control. (E) Real-time RT-PCR mea-
surements of HCV RNA replication. The relative HCV RNA copy
number represents the copy number for each construct relative to a
replication-lethal GND mutant, normalized to the value present 4 h
after transfection. Results shown represent the means  SE calculated
from triplicate RT-PCR assays.
FIG. 6. Inhibition of virus production by DMAT, an inhibitor of
CK II. (A) Following transfection of the indicated RNA, cells were
treated with the indicated concentration of DMAT for 48 h. The
medium was then replaced with fresh medium (no drug), followed 24 h
later by the harvesting of supernatant fluids for virus titration.
Means  SE were calculated from duplicate experiments. (B) Immu-
noblots for NS5A, NS2, NS3, and GAPDH from cell lysates prepared
72 h after transfection. (C) Cytotoxic effects of DMAT assessed by a
WST-1 cellular proliferation assay. Means  SE were calculated from
triplicate experiments.
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phosphorylation, or which cellular kinases are responsible for
it. Ser-349, near the C terminus of domain II, was suggested
previously to be a major site of phosphorylation in the wild-
type H77S NS5A protein (34), while mutational analyses sug-
gested that phosphoacceptor sites in domain III are important
for basal phosphorylation (1). While Ala replacements of these
residues generally do not affect RNA replication, Tellinghu-
isen et al. (39) suggested previously that the CK II-mediated
phosphorylation of Ser-457 of the JFH-1 NS5A protein (do-
main III) is essential for intracellular virus assembly. Ser-457
was predicted to be a site of CK II phosphorylation by the
Web-based NetPhosK server (5). It is located within an ideal
sequence context for CK II phosphorylation, just upstream of
several acidic residues (“SEED,” where S is Ser-457) (39).
Although the amino acid sequences of domain III of the JFH-1
and H77S proteins have only 46% identity, there are two short
regions of exact identity: H77S residues 414 to 428 (also resi-
dues 414 to 428 in JFH-1) and residues 431 to 435 (residues
451 to 455 in JFH-1) (Fig. 7A). Interestingly, the latter of these
two regions of identity is immediately upstream of Ser-457 in
the JFH-1 sequence (Fig. 7A). This sequence also overlaps a
domain identified previously by Masaki et al. (28) (residues
452 to 457) as being essential for the recruitment of NS5A to
the core protein decorating lipid droplets, a necessary early
step in JFH-1 virus assembly (29). While the results of Tellin-
ghuisen et al. (39) and those of Masaki et al. (28) differ signif-
icantly in some respects, in aggregate they suggest that 3 po-
tential Ser phosphoacceptor sites within this region (Ser-452,
Ser-454, and Ser-457) are important for JFH-1 assembly. All
three of these Ser residues are conserved in the H77S sequence
(Ser-432, Ser-434, and Ser-437) (Fig. 7A), and their presence
in the H77S protein could thus account for the ability of H77S
FIG. 7. Impact of Ala substitutions at potential Ser/Thr phosphoacceptor site residues in domain III of H77S on viral RNA replication and
infectious virus production. (A) Possible Ser/Thr phosphoacceptor sites in the C-terminal region of domain III of the NS5A proteins of JFH-1 and
H77S viruses. At the top, the H77S and JFH-1 sequences are aligned: Ser residues previously found to be important for the NS5A-core interaction
and the assembly and release of infectious JFH-1 virus by Masaki et al. (28) (red box) and Ser-457, identified by Tellinghuisen et al. (39) as a site
of CK II phosphorylation (red arrow), are highlighted. Within the related H77S sequence, Ser-438 and Thr-442 are possible sites of CK II
phosphorylation predicted by the NetPhos 1.0 server. Below are the C-terminal NS5A sequences of the single- and multiple-Ala-substitution
mutants studied. Potential Ser/Thr phosphoacceptor sites studied are shown in red, while Ala substitutions ablating these sites in the mutants are
shown in boldface type. (B) Potential phosphorylation sites near the C terminus of domain III of H77S NS5A were mutated to Ala to assess their
role(s) in infectious virus production. Shown are the mean virus yields following the transfection of the mutant RNAs, normalized to that of the
H77S virus (100% 	 mean of 160 FFU/ml)  SE from two independent transfections. (C) HCV RNA replication compared to the replication-
lethal GND mutant measured by a real-time RT-PCR assay. The means  SE were calculated from triplicate RT-PCR assays. (D) Immunoblots
for HCV NS5A, core, and GAPDH in lysates of RNA-transfected cells. Pred. m.w., predicted molecular weight (in thousands).
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domain III to function in the assembly of the JFH-1/H5Ad3
virus. However, the H77S sequence lacks the CK II “SEED”
motif identified previously by Tellinghuisen et al. (39), and the
NetPhos 1.0 server predicts instead (with very low probability)
the CK II phosphorylation of Ser-438 and Thr-442 (Fig. 7A).
To ascertain the role of these H77S residues in the assembly
and release of the H77S virus, we created a series of 5 H77S
RNA mutants in which Ser-432, Ser-434, Ser-437, Ser-438, and
Thr-442 were individually replaced with Ala and assessed their
abilities to produce infectious virus following transfection into
Huh-7.5 cells. The results of these experiments, repeated with
each construct in at least two replicate experiments with inde-
pendently transcribed RNAs, are shown in Fig. 7B. Each of
these single-site mutations had an adverse impact on infectious
virus production, with the most profound effect being associ-
ated with S434A (70% reduction in the infectious virus yield)
and T442A (60%). Alanine substitutions at Ser-437 and Ser-
438 had only a modest impact (45% decrease), while the
S432A mutant was least affected (35%). Because Masaki et
al. (28) found cumulative effects of multiple Ala substitutions
in this region of the JFH-1 protein, we also evaluated several
H77S mutants in which two of the five potential Ser/Thr phos-
phoacceptor sites were replaced with Ala. Two of these mu-
tants demonstrated substantially greater defects in virus pro-
duction: mutant AWA, containing both S432A and S434A
substitutions (92% reduction), and mutant ASA, containing
both S437A and T442A substitutions (88% reduction) (Fig.
7B). While none of the double-Ala substitutions that we eval-
uated completely abolished infectious virus production, no de-
tectable infectious virus was released from cells transfected
with a mutant in which each of the 4 suspect Ser residues was
replaced with Ala (mutant 4SA) (Fig. 7B). Importantly, the
mutants demonstrating the greatest defects in infectious virus
production were capable of nearly wild-type RNA replication
(Fig. 7C), and cells transfected with these RNAs expressed
core at an abundance equal to or only slightly reduced from
that of the parental H77S RNA (Fig. 7D, compare lane 3 with
lanes 4 and 5). The results of this mutational analysis thus
indicate that the assembly and release of infectious genotype
1a H77S virus, like genotype 2a JFH-1 virus (28), are likely to
be dependent upon the phosphorylation of several members of
a cluster of conserved Ser residues near the extreme C termi-
nus of domain III. While a role for Thr phosphorylation in
NS5A has not been identified previously for HCV assembly,
Thr-442 appears to be necessary for the efficient production of
the H77S virus but is not by itself sufficient in the absence of
two or more of the upstream Ser residues.
To assess the impact of these mutations on the phosphory-
lation status of NS5A, we subjected lysates of RNA-transfected
cells to immunoblot analysis. Lysates of cells containing geno-
type 1a (H77) and genotype 1b (HCV-N) replicons (17, 46)
were studied in parallel, as this comparison provided some
additional information on the phosphorylation status of NS5A
expressed by H77S RNA. Lysates of HCV-N replicon cells
demonstrated two distinct NS5A bands, the lower of which
accounted for most of the protein present and the upper of
which, while of low abundance, comigrated in SDS-PAGE gels
with the single NS5A band present in either the H77S replicon
cells or cells transfected with H77S RNA (Fig. 7D, compare
lane 2 with lanes 1 and 3). Since the genotype 1a H77S and
genotype 1b HCV-N proteins have relatively similar predicted
molecular masses in the absence of posttranslational modifi-
cations (49.1 and 48.8 kDa, respectively), this suggests that the
single H77S band that we observed is likely to represent the
hyperphosphorylated form of the protein. Importantly, little
NS5A protein was detected in lysates of the AWA and 4SA
mutant-transfected cells (Fig. 7D, lanes 4 and 5). A very faint
band migrating slightly faster than that of H77S NS5A was
evident in the AWA lysates with increased exposure times
(lane 4, marked by “o”), while no NS5A was detected in 4SA
mutant-transfected cell lysates despite the presence of appre-
ciable amounts of the core protein.
Rescue of virus production with Ala-to-Asp substitutions in
AWA and 4SA mutants. To more completely document the
loss of infectious virus production accompanying the 4SA mu-
tation in the H77S virus (Fig. 7B), we engineered these muta-
tions into pH77S.3, a modified version of pH77S that produces
5-fold more infectious virus from RNA-transfected cells (our
unpublished data). In replicate experiments, H77S.3 produced
over 700 FFU/ml by 3 days posttransfection, while no virus
(
10 FFU/ml) was produced by H77S.3/4SA (Fig. 8A), con-
firming almost a 100-fold reduction in infectious virus produc-
tion with Ala substitutions at these 4 residues near the C
terminus of NS5A. To determine whether the replacement of
these Ala substitutions with a residue containing a phospho-
mimetic side chain, Asp, would rescue the production of in-
fectious virus, we constructed an H77S.3/4SD mutant as well as
H77S.3/DWD in which the Ala residues at positions 432 and
434 (Fig. 7B) were replaced with Asp. In sharp contrast to the
AWA mutant, H77S.3/DWD produced almost as much infec-
tious virus as H77S.3, while the 4SD mutant regained the
capacity to produce infectious virus, albeit at a level substan-
tially lower than that of H77S.3 (Fig. 8B). Remarkably, NS5A
expression, which was much reduced with the AWA and 4SA
mutants despite the absence of any significant reduction in
viral RNA synthesis, was largely restored with the DWD and
4SD mutants (compare Fig. 7D with 8B, bottom). Taken col-
lectively, the data shown in Fig. 7 and 8 are strongly suggestive
of the need for phosphorylation at 2 or more of the 4 Ser
residues located at positions 432, 434, 437, and 438 of NS5A
for the production of infectious H77S virus. The changes noted
for the apparent abundance of NS5A in the mutants (Fig. 7D
and 8A) may be due in part to the decreased stability of the
mutant proteins. When ectopically expressed as Myc-tagged
proteins in Huh-7.5 cells, the abundance of H77S/4SA ranged
from 55 to 71% of that of the wild-type H77S protein (depend-
ing on whether it was detected in immunoblots with the 9E10
monoclonal antibody or anti-Myc), while H77S/4SD was 1.5- to
1.9-fold more abundant (Fig. 3B).
DISCUSSION
A long-standing limitation of hepatitis C virus research has
been a lack of virus strains that are capable of replicating well
both in cell culture and in chimpanzees, still the only available
animal model of chronic hepatitis C virus. While self-amplify-
ing RNA replicons have been successfully established by using
cloned sequences from multiple HCV strains, very few viral
RNAs can be coaxed to produce detectable quantities of in-
fectious virus in cell culture (33, 44, 49). This may be due in
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part to conflicting effects of cell culture-adaptive mutations on
RNA replication and infectious particle production (7, 33), but
many gaps remain in our understanding of the process of virus
assembly. Multiple lines of evidence support a role for NS5A,
and in particular domain III of NS5A, in the assembly of
infectious HCV particles (2, 16, 28, 39). We studied the role of
this domain in the genotype 1a H77S virus by creating chimeric
viruses in which the entire NS5A sequence or only domain III
was swapped between it and the JFH-1 virus (genotype 2a).
Both of these HCV RNAs are competent for infectious virus
production when transfected as RNA into permissive cells, but
they generate quantitatively different yields of virus. Cells
transfected with H77S RNA release between 102 and 103
FFU/ml into cell culture supernatant fluids between 48 and
72 h after transfection under the conditions used in this study,
while JFH-1 RNA produces approximately 10-fold more at
these early time points (Fig. 2A). While the exchange of the
entire NS5A sequence resulted in RNAs that were impaired in
their abilities to replicate in transfected cells, the domain III
chimeric RNAs replicated well and produced infectious prog-
eny albeit with altered efficiencies. Although the domain III
sequences of these two viruses share less than 50% amino acid
identity, these experiments demonstrate the existence of a con-
served assembly function in domain III that can function in the
context of either a genotype 1a or 2a virus background.
A rather surprising result to emerge from these studies was
the increase that we observed for the production of infectious
JFH-1 virus when domain III from the H77S virus, which
produces relatively low virus yields, replaced the related se-
quence in JFH-1 (Fig. 2A). This result shows clearly that the
contrasting capacities of the JFH-1 and H77S genomes to
produce infectious particles result from differences in the ge-
nomes outside domain III of NS5A. Nonetheless, we observed
a good correlation between the apparent abundance of the
NS5A protein and the efficiency of infectious virus production:
across both chimeras and the 2 parental genomes, the abun-
dance of NS5A and the production of infectious virus were
similarly ordered (Fig. 1D). Although matched to some extent
by differences in core protein expression levels, the differences
in NS5A abundances could not be explained entirely by an
altered RNA replication efficiency, as the domain III swaps
had a minimal impact on this (Fig. 1C). The contrasts that we
observed for the abundances of NS5A in JFH-1 versus H77S
RNA-transfected cells were not mirrored by similar differences
in the abundances of NS5A when these proteins were ex-
pressed ectopically in Huh-7.5 cells (Fig. 3). While this suggests
that the stabilities of JFH-1 NS5A and H77S NS5A are not
intrinsically different, JFH-1 NS5A was mostly hypophosphor-
ylated when expressed as a solitary protein, and it remains
possible that there are significant differences in the stabilities
of NS5A expressed from replication-competent H77S and
JFH-1 RNAs.
Within the domain III sequences of JFH-1 and H77S, there
are 2 regions with striking amino acid identity that reside near
the C terminus of NS5A and are separated by a large insertion
in the JFH-1 sequence (Fig. 7A). The most C terminal of these
regions of identity contains a number of potential phosphoac-
ceptor sites that were strongly implicated in the assembly of the
JFH-1 virus by Tellinghuisen et al. (39) and Masaki et al. (28).
We observed that Ala substitutions at conserved Ser residues
in this region had a strong negative impact on the production
of infectious virus from H77S RNA (Fig. 7B), suggesting that
the shared domain III assembly functions of the H77S and
JFH-1 proteins may be dependent upon these conserved resi-
dues. Ala substitutions at these sites also caused a marked
reduction in the abundance of NS5A without similar changes
in viral RNA replication efficiency or core protein expression
(Fig. 7C and D). Although a direct biochemical investigation of
NS5A phosphorylation was outside the scope of the experi-
ments that we report in this communication, the latter results,
coupled with the positive impact of phosphomimetic substitu-
tions at these residues (Fig. 8B), support the possibility that
FIG. 8. Phosphomimetic Ala-to-Asp substitutions restore production of infectious virus by AWA and 4SA mutant RNAs. Shown are infectious
virus yields from cells transfected with H77S.3 and H77S.3/4SA RNAs (A) and H77S.3, H77S.3/DWD, and H77S.3/4SD mutants (B). Results
shown are the means  SE from two transfections with independent RNA transcripts. At the bottom are immunoblots of NS5A and core protein
expression with actin (A) and GAPDH loading controls (B).
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these are phosphoacceptor sites. Mutations at these residues
cause modest changes in the stability of NS5A, as indicated by
differences in protein abundance when H77S NS5A was ex-
pressed ectopically (Fig. 3B). More pronounced changes in
stability could result directly from the altered phosphorylation
of NS5A when expressed from a replication-competent RNA
or from changes in its ability to interact with other viral pro-
teins, including core (28), or any of its numerous cellular bind-
ing partners (43). Unfortunately, NS5A expression from H77S
RNA, and particularly from these NS5A mutants, was insuffi-
cient for direct pulse-chase measurements of protein stability.
The NetPhosK prediction program (5) suggests that Ser-457
in JFH-1 NS5A may be phosphorylated by CK II. This is
consistent with its location upstream of several acidic residues
and with the results of Tellinghuisen et al. (39). This residue is
also located within the C-terminal region of JFH-1/H77S se-
quence identity described above (Fig. 7A) and lies within the
Ser cluster identified previously by Masaki et al. (28) (residues
452 to 457) as being essential for the recruitment of NS5A to
the core protein associated with lipid droplets during early
JFH-1 virus assembly (29). The amino acid sequence of this
region of JFH-1 NS5A (SWSTCS [residues 452 to 457]) differs
from that of H77S by only a single residue (SWSTVS [residues
432 to 437]) (Fig. 7A). However, there are fewer acidic resi-
dues downstream of the conserved Ser-437 in H77S (homolo-
gous to Ser-457 in JFH-1) and only low-probability predictions
of CK II phosphorylation in this region of domain III by the
NetPhos I.0 server at Ser-438 and Thr-442. Although infec-
tious virus production by JFH-1 and JFH-1/H5Ad3 RNA was
inhibited to a similar extent by DMAT, a CK II inhibitor (Fig.
6), an Ala substitution at Ser-437 in domain III of H77S caused
only a modest decrease in infectious virus yield (Fig. 7B). The
Ser-437-to-Ala mutation was not as inhibitory to virus produc-
tion as similar Ala substitutions at Ser-434 or Thr-442. At-
tempts to assess the impact of the small interfering RNA
(siRNA)-mediated knockdown of either or both of the CK II
isoforms did not provide a clear answer as to the role of this
kinase in the H77S NS5A-mediated production of infectious
virus (data not shown). Taken together, however, our results
indicate that there is no special role for Ser-437 phosphoryla-
tion in the production of infectious H77S virus and suggest
instead that virus production is dependent upon multiple Ser
residues, and likely Thr-442 as well, acting in a redundant or
possibly cooperative fashion. Phosphorylation at Ser-437, or
any of the other residues in JFH-1 identified by Masaki et al.
(28) or in H77S identified by us (Fig. 7), could modulate
phosphorylation elsewhere in NS5A, including at other con-
served residues within the C terminus of domain III.
These findings with the H77S virus are thus more consistent
with the role of the serine cluster identified previously by
Masaki et al. (28) in JFH-1 assembly than with the uniquely
important role for Ser-457 phosphorylation suggested previ-
ously by Tellinghuisen et al. (39). While there is no clear
explanation for the differences observed in these two prior
studies of NS5A, it may be important that Masaki et al. (28)
studied the assembly of the JFH-1 virus, while Tellinghuisen et
al. (39) studied a J6/JFH-1 chimera in which the structural
proteins were derived from another genotype 2a virus, J6.
While both viruses were entirely genotype 2a in sequence,
differences in the structural proteins could well have influ-
enced the requirements for the phosphorylation of residues in
domain III of NS5A. However, it is important to recognize in
the context of this discussion that no study, including that
described here, has yet directly demonstrated the phosphory-
lation of any residues in domain III of NS5A.
Although the JFH-1 virus has provided a very useful model
system that recapitulates the entire HCV life cycle in cultured
cells (44, 52), most persons with significant HCV-related liver
disease are infected with genotype 1 viruses (51). It is impor-
tant that findings to emerge from the JFH-1 system are also
examined in a genotype 1 background, as we have done here
with the role of domain III of NS5A in H77S assembly. An
analysis of almost 600 different HCV sequences shows that the
NS5A domain III sequence of H77S is broadly representative
of all genotype 1a viruses and similar in many respects to the
sequence of genotype 1b viruses as well (Fig. 9). Interestingly,
this analysis revealed that while the Thr residue present at
position 442 is typical of most genotype 1a NS5A sequences,
the Thr residue that aligns with it at position 462 of JFH-1 is
not found in most genotype 2a viruses. Despite considerable
sequence divergence and potential differences in the contribu-
tions of specific residues to the assembly of infectious virus
among different genotypes, our results point to similar mech-
anisms for the regulation of HCV assembly by domain III of
FIG. 9. Sequence logo depiction of amino acid sequence conservation within domain III of NS5A among genotype 1a (224 sequences),
genotype 1b (357 sequences), and genotype 2a (18 sequences) strains of HCV from the European HCV Database (euHCVdb) (8). Sequences were
aligned with MUSCLE (10), with minor manual modifications, and logos were generated with WebLogo (9). The height of each single-character
amino acid code is proportional to the representation of that amino acid at each position. The sequence extending from Ser-432 to Thr-442, which
contains potential phosphoacceptor residues in H77S, is boxed in red. To show how representative the H77S sequence is of other genotype 1
viruses, residues identical to those in H77S are shown in blue in the genotype 1a and 1b sequences, while residues that differ from those in H77S
are shown in gray. Residues identical to JFH-1 are shown in red in the genotype 2a sequence.
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both genotype 1a and 2a viruses. Still to be explained is why
H77S lags so far behind JFH-1 in the production of infectious
virus.
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